Compare BJDX & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJDX | ZCMD |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 2.0M |
| IPO Year | 2021 | 2019 |
| Metric | BJDX | ZCMD |
|---|---|---|
| Price | $1.06 | $1.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.8M | ★ 9.2M |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $249,040.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $0.02 |
| 52 Week High | $7.00 | $11.96 |
| Indicator | BJDX | ZCMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.07 | 48.13 |
| Support Level | $0.63 | $0.75 |
| Resistance Level | $2.10 | $3.11 |
| Average True Range (ATR) | 0.18 | 1.31 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 3.90 | 0.75 |
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.